Skip to main content Scroll Top
Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
Most Viewed Posts
Clear Filters
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
16 March 2026
REGEnLIFE tests light stimulation on neurodegenerative diseases
REGEnLIFE tests light stimulation on neurodegenerative diseases
23 May 2023
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases
7 February 2025
24 October 2023

Clinical Trials on Alzheimer’s Disease (CTAD CHINA)

Read the article

Jacques Touchon (MD, PhD), University of Montpellier and Guillaume Blivet (MPH), REGEnLIFE, France.

Share this article